While heart disease consists of many conditions, blockages in the artery are the most common. This can prevent blood, and oxygen, from getting to the heart and can lead to a heart attack or death.
Biomarkers give clues to which women are of greater risk of developing cardiovascular disease in the future and could lead to early interventions, such as lifestyle modification, to reduce the risks.
Since symptoms such as fatigue and dyspnea are common to many heart and lung diseases, pulmonary hypertension often flies under the radar of respirologists and other health professionals.
The European Pharmacovigilance Risk Assessment Committee reviewed reported cases and post-marketing safety data to evaluate the risks of PRES and RCVS with pseudoephedrine-containing medicines.